Clinical Skiills
Jayne Charlamb, MD, FACP, FABM, IBCLC
Director, Division of Breast Health and Breastfeeding Medicine
SUNY Upstate Medical University
Manlius, New York, United States
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Davia Moss
Family Nurse Practitioner
SUNY Upstate University Hospital
Syracuse, New York, United States
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Abstract: Pregnancy Associated Breast Cancer (PABC) includes breast cancers diagnosed during pregnancy or within 1-2 years postpartum. PABC affects 1 in 3000 births and is increasing in incidence, likely due to increasing age at time of pregnancy. PABC most commonly presents with a palpable breast change, and delay in diagnosis has been well-documented. Clinical evaluation of breast complaints in pregnant or lactating patients should proceed expeditiously and should not differ from management in non-gravid/non-lactating patients. Treatment decisions for PABC should be made using a patient-centered, multi-disciplinary team approach using a shared-decision-making model. Overall goals may be competing in nature, and typically include prolonging and protecting the breast cancer patient's life, protecting the fetus/infant, and protecting the breast cancer patient's future reproductive potential. Initiating and continuing lactation during diagnosis and treatment for PABC is often possible, and the risks, benefits, possibilities, and alternatives of initiating and/or continuing lactation should be discussed with every patient diagnosed with PABC. Incorporation of skilled and knowledgeable lactation/breastfeeding medicine support is crucial in supporting a patient with PABC to start, continue, or stop lactation, and lactation consultants/breastfeeding medicine specialists should be incorporated in the oncology care team. We will present a case of a woman diagnosed with PABC late in pregnancy who successfully initiated and continued lactation during her breast cancer journey. The patient will candidly share her experience in her own words.
Publication: N/A
Diversity and Inclusion: Where possible/relevant in the presentation, we will use inclusive language and acknowledge a range of presentations and perspectives that may differ from that of the patient in the case being presented.
Disclosures: Presenter(s) indicated no conflicts of interest to disclose. The FDA has not cleared all pharmaceuticals and/or medical devices for the use described in this presentation.
Lead Author: Jayne R. Charlamb, MD, FACP, FABM, IBCLC – SUNY Upstate Medical University
Co-Author: Davia Moss – SUNY Upstate University Hospital
Lead Author: Jayne R. Charlamb, MD, FACP, FABM, IBCLC – SUNY Upstate Medical University
Co-Author: Davia Moss – SUNY Upstate University Hospital
Lead Author: Jayne R. Charlamb, MD, FACP, FABM, IBCLC – SUNY Upstate Medical University
Co-Author: Davia Moss – SUNY Upstate University Hospital
Lead Author: Jayne R. Charlamb, MD, FACP, FABM, IBCLC – SUNY Upstate Medical University
Co-Author: Davia Moss – SUNY Upstate University Hospital
Lead Author: Jayne R. Charlamb, MD, FACP, FABM, IBCLC – SUNY Upstate Medical University
Co-Author: Davia Moss – SUNY Upstate University Hospital